propagated in CBA/Ca mice was transplanted s.c. into a congenic strain bearing an isoenzyme (GPI) and chromosome (T6) difference from the last strain. After 4 successive passages in the new host, the tumour, when excised and homogenized, was found to possess a mixture of two GPI phenotypes, one derived from the original tumour cells and the other from the new host. During subsequent tissue culture, fusion appeared to occur between tumour and host cells as indicated by the detection of the heterogeneous (a/ dimer) isoenzyme of GPI. The proportion of heterogeneous GPI increased rapidly in cultured cells which formed tumours showing the same GPI pattern when inoculated s.c. into mice of the original host strain. Although interand intraspecific hybrid cells can be induced in culture by viral action, we describe an example of apparently spontaneous fusion between tumour and adventitious host cells. Monitoring of GPI isoenzymes can provide a quantitative assessment of fusion between the cells from strains of mice which are heterogeneic for Gpi-1.
The tumour was originally induced in CBA/H mice and maintained by s.c. transplantation in CBA/Ca mice for 8 years. The congenic CBA/H-T6.A-Gpi_1a line was produced by 11 generations of backcrossing strain A into CBA/H-T6 mice Accepted 22 July 1982 with selection of GPI-1AB, followed by brother-sister incrossing to obtain homogeneous Gpi-la progeny. The CBA/H-T6 strain is congenic with our CBA/Ca strain.
Transplant tolerance between all these lines was confirmed by skin grafting.
A cell suspension from the solid tumour was obtained using trypsin (025% GPI isoenzymes were assayed by the method of Marshall & Worsfold (1978) . This method consists of a micro-preparative electrophoresis apparatus linked to an auto-analysis system for GPI. Fig. 1 isoenzymes in the proportion 1: 2: 1.) Cells which remained adherent to the substrate after EDTA/trypsin treatment yielded patterns which were either polymorphic, with a predominance of GPI-1AB pattern, or were entirely of GPI-1AB phenotype, within the quantitative limits of the assay (about 500). The GPI pattern of these latter cells was indistinguishable in terms of the proportions of peak areas from the GPI pattern obtained from a red cell haemolysate derived from a (Gpi-lb x Gpi-la) hybrid mouse. These adherent cells were passaged 3 x further and a GPIlAB phenotypic pattern was obtained for cells at the end of each passage. One million of these cells were introduced s.c. into 3 GPI-1B mice and within 2 weeks a tumour was palpable in each. At 5 weeks the tumours were excised and the GPI pattern of this material was found to be polymorphic, approximately equivalent to the combination of 29% of GPI-1B phenotype with 76% GPI-IAB.
Monitoring the GPI of cultured cells derived from those detached by EDTA/ trypsin showed, during 3 passages, a gradual change from the polymorphic GPI-1AB and GPI-1B pattern to a monomorphic GPI-1AB pattern (Table) .
The morphological changes observed during culture of tumour cells are shown in Fig. 2 . The culture after 3 days growth showed an indistinct layer of epithelioid cells covered with macrophage-like cells (Fig. 2a) . This morphology was retained in the adherent cell population after treatment with EDTA/trypsin. After the second passage at 6 days, large multinucleate cells appeared (Fig. 2b) passage at 28 days, discrete colonies of epithelioid cells with a single, large nucleus developed ( Fig. 2c) and grew rapidly to confluence at the expense of all other cell types. These were the cells that possessed a stable GPI-1AB phenotype that was retained for at least 3 further passages. Mitotically active cultures were exposed to 0-0040o colchicine for 17 h. Dividing cells, arrested in metaphase, became detached from the culture vessel and were collected by centrifugation.
Mice were injected (i.p.) with 03 ml of 0-0400 colchicine and killed after 1 I h. Cell suspensions were prepared by mincing pieces of tumour in warm Medium 199 (Flow Laboratories).
Chromosome preparations were prepared and stained with propionic orcein (Ford, 1966) .
The T6 marker chromosome from the host mouse was detected in some polyploid metaphases in tumour cells after 3 passages in culture.
The weight of evidence for cell fusion in this study rests on the interpretation of GPI data although the karyotypic and morphological observations reinforce this conclusion. In order for the heterogeneous (oq3) isoenzyme to be produced both Gpi-la and Gpi-lb genes must be present within the same cell (DeLorenzo & Ruddle, 1969) . These authors showed that allophenic (chimaeric) animals do not show heterogeneous (oi) isoenzyme except in extracts of multinucleate cells. The demonstration of heterogeneous (oj3) GPI isoenzyme has been used as evidence of cell fusion recently by Halaban et al. (1980) . They found that mixed populations of cells carrying the Gpi-la and Gpi-lb genes did not produce the (a8) isoenzyme nor was this isoenzyme produced by freezing and thawing cell lysates at low ionic strength. Throughout many bone marrow transplant experiments in which we are currently engaged, where homozygous GPI isoenzymes have been used to monitor the graft, no heterogeneous (ox/) form has been detected.
The possibility was considered that the tumour cells in culture after passage 3 may have been producing disproportionate amounts of the sub-band shown in Fig. la which migrates at about the position of the heteroeneous (op) isoenzyme. Two observations make this unlikely: first, the ratio of this sub-band to the preceding major band to which it is related, is constant in a wide range of tissues (Marshall et al., 1979) including this osteosarcoma. Second, when cells from the same tumour line grown in a GPI-1B mouse were cultured for 3 passages under the same conditions as for the tumour cells from the GPI-1A host, no increase in the ratio of the sub-band to main band was observed.
There have been several reports of spontaneous intraspecific hybridization between malignant and normal cells (Scaletta & Ephrussi, 1965; Halaban et al., 1980) and this process can apparently occur in vivo (Ber et al., 1978) . Thus, Nabholz et al. (1969) and Wiener et al. (1972) have discussed the possibility that fusion between malignant and normal cells in vivo could be a mechanism of tumour progression and evolution. Cell fusion could provide a basis for increased genetic variation within the tumour cell populations and on this variation selection could operate. In these reports the demonstration of fusion has relied on deliberate selection for fused cells, usually by the selective medium HAT in which endogenous synthesis of nucleic acid is blocked by aminopterin (Littlefield, 1964) . In the current work we present evidence that fusion has occurred between normal and malignant cells in the absence of any added fusing agent and without deliberate selection for fused cells. The presence of a viral fusion agent in our cultures was considered unlikely since growth medium from the fused cell culture failed to induce fusion of mouse calvarial fibroblasts, as indicated by the absence of (ou) isoenzyme in a mixed population of GPI-1A and GPI-1B cultured cells (unpublished data).
The ability to fuse appears to have been a property of the cultured tumour cells. It seems that the culture conditions either encouraged fusion or selected for the fused cells. We came to this conclusion because fusion was not detected in vivo. Detection of small numbers of fused cells in the tumour presents technical difficulties because of the sub-band already mentioned. If fusion of cells had occurred in vivo these may have been suppressed by the host. There is evidence that malignancy can be suppressed by fusion be-tween malignant and normal cells and that malignancy of the hybrids is not simply related to immunogenicity (Kim et al., 1979) .
Whether malignancy behaves as a recessive or dominant characteristic in this type of fused cell is a vexed question. Stanbridge (1976) points to the tendency for "most mouse cell lines to transform into heteroploid malignant cell lines in vitro" and he also states that the lack of suppression of malignancy in fused mouse cell lines may be due to rapid loss of chromosomes.
The GPI data presented here do not allow a distinction between cells derived by nuclear fusion (polyploid) and multinucleate cells with nuclei of different provenance. We have, however, obtained patterns which show a preponderance of heterogeneous (a#) isoenzyme which could not be derived from simple addition of GPI-1A, 1B, and LAB phenotypic patterns, in that the proportion of oxcx isoenzyme was too low, relative to the amount of ax,8 isoenzyme. This can only arise if the a and 3 subunits are synthesized in the cell in unequal proportions.
The observations of the rapid preferential selection of fused cells in vitro in the absence of added selective agents lends support to the possibility of this being a mechanism of tumour cell evolution in vivo. It may be worth bearing in mind the possibility of fusion occurring in cultured tumour cell experiments, adding difficulty to their interpretation.
